Complications of ICD Generator Change and Implantations

Cardiac Electrophysiology Clinics

Volumn 3, Issue 3, 2011, Pages 389-401

  Prutkin, Jordan M ^a   Poole, Jeanne E ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiac implantable electronic device infection; Complications; Generator change; ICD; ICD leads

Indexed keywords

ANTIARRHYTHMIC AGENT; HEPARIN; WARFARIN;

ADRENAL DISEASE; AIR EMBOLISM; APNEA; ARTERIOVENOUS FISTULA; BLEEDING; BLOODSTREAM INFECTION; BRADYCARDIA; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOGENIC SHOCK; CHYLOTHORAX; CORONARY ARTERY PERFORATION; DEFIBRILLATOR; DEVICE INFECTION; DEVICE SAFETY; FROZEN SHOULDER; HEALTH CARE COST; HEART ATRIUM ARRHYTHMIA; HEART FAILURE; HEART INFARCTION; HEART VENTRICLE ARRHYTHMIA; HEMATOMA; HEMATOTHORAX; HOSPITALIZATION; HUMAN; INFECTIOUS COMPLICATION; KELOID; LUNG EDEMA; LUNG EMBOLISM; MEDIASTINUM DISEASE; NERVE INJURY; PACEMAKER ELECTRODE; PERICARDITIS; PERILYMPH FISTULA; PERIOPERATIVE COMPLICATION; PNEUMOTHORAX; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PULSE GENERATOR; REVIEW; SEPSIS; STROKE; TACHYCARDIA; TRICUSPID VALVE DISEASE; TRICUSPID VALVE REGURGITATION; UPPER EXTREMITY DEEP VEIN THROMBOSIS; VEIN OCCLUSION; WOUND DEHISCENCE;

EID: 80052288799     PISSN: 18779182     EISSN: 18779190     Source Type: Journal    
DOI: 10.1016/j.ccep.2011.05.005     Document Type: Review

References (86)

1. Moss A.J., Hall W.J., Cannom D.S., et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996, 335(26):1933-1940.
2. Moss A.J., Zareba W., Hall W.J., et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002, 346(12):877-883.
3. Bansch D., Antz M., Boczor S., et al. Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the Cardiomyopathy Trial (CAT). Circulation 2002, 105(12):1453-1458.
4. Kadish A., Dyer A., Daubert J.P., et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 2004, 350(21):2151-2158.
5. Hohnloser S.H., Kuck K.H., Dorian P., et al. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med 2004, 351(24):2481-2488.
6. Ravindran B.K., Poole J.E., Johnson G.W., et al. Timing of device-specific ICD complications: analysis of the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Heart Rhythm 2010, 7(5 Suppl 1):S9. [abstract].
7. Steinbeck G., Andresen D., Seidl K., et al. Defibrillator implantation early after myocardial infarction. N Engl J Med 2009, 361(15):1427-1436.
8. Kron J., Herre J., Renfroe E.G., et al. Lead- and device-related complications in the antiarrhythmics versus implantable defibrillators trial. Am Heart J 2001, 141(1):92-98.
9. Connolly S.J., Gent M., Roberts R.S., et al. Canadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 2000, 101(11):1297-1302.
10. Kuck K.H., Cappato R., Siebels J., et al. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH). Circulation 2000, 102(7):748-754.
11. Abraham W.T., Fisher W.G., Smith A.L., et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002, 346(24):1845-1853.
12. Cazeau S., Leclercq C., Lavergne T., et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001, 344(12):873-880.
13. Knight B.P., Desai A., Coman J., et al. Long-term retention of cardiac resynchronization therapy. J Am Coll Cardiol 2004, 44(1):72-77.
14. Leon A.R., Abraham W.T., Curtis A.B., et al. Safety of transvenous cardiac resynchronization system implantation in patients with chronic heart failure: combined results of over 2,000 patients from a multicenter study program. J Am Coll Cardiol 2005, 46(12):2348-2356.
15. Abraham W.T., Young J.B., Leon A.R., et al. Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure. Circulation 2004, 110(18):2864-2868.
16. Bristow M.R., Saxon L.A., Boehmer J., et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004, 350(21):2140-2150.
17. Cleland J.G., Daubert J.C., Erdmann E., et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005, 352(15):1539-1549.
18. Linde C., Abraham W.T., Gold M.R., et al. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. J Am Coll Cardiol 2008, 52(23):1834-1843.
19. Moss A.J., Hall W.J., Cannom D.S., et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 2009, 361(14):1329-1338.
20. Bardy G.H., Lee K.L., Mark D.B., et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005, 352(3):225-237.
21. Gras D., Bocker D., Lunati M., et al. Implantation of cardiac resynchronization therapy systems in the CARE-HF trial: procedural success rate and safety. Europace 2007, 9(7):516-522.
22. Freeman J.V., Wang Y., Curtis J.P., et al. The relation between hospital procedure volume and complications of cardioverter-defibrillator implantation from the implantable cardioverter-defibrillator registry. J Am Coll Cardiol 2010, 56(14):1133-1139.
23. Curtis J.P., Luebbert J.J., Wang Y., et al. Association of physician certification and outcomes among patients receiving an implantable cardioverter-defibrillator. JAMA 2009, 301(16):1661-1670.
24. Al-Khatib S.M., Greiner M.A., Peterson E.D., et al. Patient and implanting physician factors associated with mortality and complications after implantable cardioverter-defibrillator implantation, 2002-2005. Circ Arrhythm Electrophysiol 2008, 1(4):240-249.
25. Reynolds M.R., Cohen D.J., Kugelmass A.D., et al. The frequency and incremental cost of major complications among Medicare beneficiaries receiving implantable cardioverter-defibrillators. J Am Coll Cardiol 2006, 47(12):2493-2497.
26. Lee D.S., Krahn A.D., Healey J.S., et al. Evaluation of early complications related to De Novo cardioverter defibrillator implantation insights from the Ontario ICD database. J Am Coll Cardiol 2010, 55(8):774-782.
27. Alter P., Waldhans S., Plachta E., et al. Complications of implantable cardioverter defibrillator therapy in 440 consecutive patients. Pacing Clin Electrophysiol 2005, 28(9):926-932.
28. Gradaus R., Block M., Brachmann J., et al. Mortality, morbidity, and complications in 3344 patients with implantable cardioverter defibrillators: results from the German ICD Registry EURID. Pacing Clin Electrophysiol 2003, 26(7 Pt 1):1511-1518.
29. Kleemann T., Becker T., Strauss M., et al. Perioperative complications and hospital outcome in 1428 patients undergoing first implantation of an implantable cardioverter defibrillator: A single center experience from 1992 to 2009. Heart Rhythm 2010, 7:S9. [abstract].
30. Borleffs C.J., Thijssen J., de Bie M.K., et al. Recurrent implantable cardioverter-defibrillator replacement is associated with an increasing risk of pocket-related complications. Pacing Clin Electrophysiol 2010, 33(8):1013-1019.
31. Costea A., Rardon D.P., Padanilam B.J., et al. Complications associated with generator replacement in response to device advisories. J Cardiovasc Electrophysiol 2008, 19(3):266-269.
32. Kapa S., Hyberger L., Rea R.F., et al. Complication risk with pulse generator change: implications when reacting to a device advisory or recall. Pacing Clin Electrophysiol 2007, 30(6):730-733.
33. Moore J.W., Barrington W., Bazaz R., et al. Complications of replacing implantable devices in response to advisories: a single center experience. Int J Cardiol 2009, 134(1):42-46.
34. Poole J.E., Gleva M.J., Mela T., et al. Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures. results from the REPLACE registry. Circulation 2010, 122(16):1553-1561.
35. Gould P.A., Gula L.J., Champagne J., et al. Outcome of advisory implantable cardioverter-defibrillator replacement: one-year follow-up. Heart Rhythm 2008, 5(12):1675-1681.
36. Rosenqvist M., Beyer T., Block M., et al. Adverse events with transvenous implantable cardioverter-defibrillators: a prospective multicenter study. European 7219 Jewel ICD investigators. Circulation 1998, 98(7):663-670.
37. Takahashi T., Bhandari A.K., Watanuki M., et al. High incidence of device-related and lead-related complications in the dual-chamber implantable cardioverter defibrillator compared with the single-chamber version. Circ J 2002, 66(8):746-750.
38. Molina J.E. Perforation of the right ventricle by transvenous defibrillator leads: prevention and treatment. Pacing Clin Electrophysiol 1996, 19(3):288-292.
39. Mahapatra S., Bybee K.A., Bunch T.J., et al. Incidence and predictors of cardiac perforation after permanent pacemaker placement. Heart Rhythm 2005, 2(9):907-911.
40. Ellenbogen K.A., Wood M.A., Shepard R.K. Delayed complications following pacemaker implantation. Pacing Clin Electrophysiol 2002, 25(8):1155-1158.
41. Khan M.N., Joseph G., Khaykin Y., et al. Delayed lead perforation: a disturbing trend. Pacing Clin Electrophysiol 2005, 28(3):251-253.
42. Pfeiffer D., Jung W., Fehske W., et al. Complications of pacemaker-defibrillator devices: diagnosis and management. Am Heart J 1994, 127(4 Pt 2):1073-1080.
43. Romeyer-Bouchard C., Da Costa A., Dauphinot V., et al. Prevalence and risk factors related to infections of cardiac resynchronization therapy devices dagger. Eur Heart J 2010, 31(2):203-210.
44. Klug D., Balde M., Pavin D., et al. Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: results of a large prospective study. Circulation 2007, 116(12):1349-1355.
45. Nery P.B., Fernandes R., Nair G.M., et al. Device-related infection among patients with pacemakers and implantable defibrillators: incidence, risk factors, and consequences. J Cardiovasc Electrophysiol 2010, 21(7):786-790.
46. Uslan D.Z., Sohail M.R., St Sauver J.L., et al. Permanent pacemaker and implantable cardioverter defibrillator infection: a population-based study. Arch Intern Med 2007, 167(7):669-675.
47. Trappe H.J., Pfitzner P., Klein H., et al. Infections after cardioverter-defibrillator implantation: observations in 335 patients over 10 years. Br Heart J 1995, 73(1):20-24.
48. Samuels L.E., Samuels F.L., Kaufman M.S., et al. Management of infected implantable cardiac defibrillators. Ann Thorac Surg 1997, 64(6):1702-1706.
49. Lekkerkerker J.C., van Nieuwkoop C., Trines S.A., et al. Risk factors and time delay associated with cardiac device infections: Leiden device registry. Heart 2009, 95(9):715-720.
50. Shahian D.M., Williamson W.A., Martin D., et al. Infection of implantable cardioverter defibrillator systems: a preventable complication?. Pacing Clin Electrophysiol 1993, 16(10):1956-1960.
51. Kelly P.A., Cannom D.S., Garan H., et al. The automatic implantable cardioverter-defibrillator: efficacy, complications and survival in patients with malignant ventricular arrhythmias. J Am Coll Cardiol 1988, 11(6):1278-1286.
52. Uslan D.Z., Gleva M.J., Mela T., et al. Infections following cardiovascular implantable electronic device replacement: results from the REPLACE registry (abstract). Heart Rhythm 2010, 7(5 Suppl 1):S252.
53. Peterson P.N., Daugherty S.L., Wang Y., et al. Gender differences in procedure-related adverse events in patients receiving implantable cardioverter-defibrillator therapy. Circulation 2009, 119(8):1078-1084.
54. Maisel W.H. Pacemaker and ICD generator reliability: meta-analysis of device registries. JAMA 2006, 295(16):1929-1934.
55. Kleemann T., Becker T., Doenges K., et al. Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years. Circulation 2007, 115(19):2474-2480.
56. Kim J.B., Spevack D.M., Tunick P.A., et al. The effect of transvenous pacemaker and implantable cardioverter defibrillator lead placement on tricuspid valve function: an observational study. J Am Soc Echocardiogr 2008, 21(3):284-287.
57. Rosman J., Shapiro M.D., Hanon S. Pneumomediastinum and right sided pneumothorax following dual chamber-ICD implantation. J Interv Card Electrophysiol 2006, 17(2):157-158.
58. Ellis C.R., Rottman J.N. Increased rate of subacute lead complications with small-caliber implantable cardioverter-defibrillator leads. Heart Rhythm 2009, 6(5):619-624.
59. Danik S.B., Mansour M., Singh J., et al. Increased incidence of subacute lead perforation noted with one implantable cardioverter-defibrillator. Heart Rhythm 2007, 4(4):439-442.
60. Sterlinski M., Przybylski A., Maciag A., et al. Subacute cardiac perforations associated with active fixation leads. Europace 2009, 11(2):206-212.
61. Levy Y., Shovman O., Granit C., et al. Pericarditis following permanent pacemaker insertion. Isr Med Assoc J 2004, 6(10):599-602.
62. Hirschl D.A., Jain V.R., Spindola-Franco H., et al. Prevalence and characterization of asymptomatic pacemaker and ICD lead perforation on CT. Pacing Clin Electrophysiol 2007, 30(1):28-32.
63. Ahmed I., Gertner E., Nelson W.B., et al. Continuing warfarin therapy is superior to interrupting warfarin with or without bridging anticoagulation therapy in patients undergoing pacemaker and defibrillator implantation. Heart Rhythm 2010, 7(6):745-749.
64. Tolosana J.M., Berne P., Mont L., et al. Preparation for pacemaker or implantable cardiac defibrillator implants in patients with high risk of thrombo-embolic events: oral anticoagulation or bridging with intravenous heparin? A prospective randomized trial. Eur Heart J 2009, 30(15):1880-1884.
65. de Oliveira J.C., Martinelli M., Nishioka S.A., et al. Efficacy of antibiotic prophylaxis before the implantation of pacemakers and cardioverter-defibrillators: results of a large, prospective, randomized, double-blinded, placebo-controlled trial. Circ Arrhythm Electrophysiol 2009, 2(1):29-34.
66. Rozmus G., Daubert J.P., Huang D.T., et al. Venous thrombosis and stenosis after implantation of pacemakers and defibrillators. J Interv Card Electrophysiol 2005, 13(1):9-19.
67. Emmel M., Sreeram N., Brockmeier K., et al. Superior vena cava stenting and transvenous pacemaker implantation (stent and pace) after the Mustard operation. Clin Res Cardiol 2007, 96(1):17-22.
68. Lin G., Nishimura R.A., Connolly H.M., et al. Severe symptomatic tricuspid valve regurgitation due to permanent pacemaker or implantable cardioverter-defibrillator leads. J Am Coll Cardiol 2005, 45(10):1672-1675.
69. Borleffs C.J.W., van Erven L., van Bommel R.J., et al. Risk of failure of transvenous implantable cardioverter-defibrillator leads. Circ Arrhythm Electrophysiol 2009, 2(4):411-416.
70. Ellenbogen K.A., Wood M.A., Shepard R.K., et al. Detection and management of an implantable cardioverter defibrillator lead failure: incidence and clinical implications. J Am Coll Cardiol 2003, 41(1):73-80.
71. Hauser R.G., Hayes D.L. Increasing hazard of Sprint Fidelis implantable cardioverter-defibrillator lead failure. Heart Rhythm 2009, 6(5):605-610.
72. Parkash R., Crystal E., Bashir J., et al. Complications associated with revision of Sprint Fidelis leads: report from the Canadian Heart Rhythm Society Device Advisory Committee. Circulation 2010, 121(22):2384-2387.
73. Cabell C.H., Heidenreich P.A., Chu V.H., et al. Increasing rates of cardiac device infections among Medicare beneficiaries: 1990-1999. Am Heart J 2004, 147(4):582-586.
74. Voigt A., Shalaby A., Saba S. Continued rise in rates of cardiovascular implantable electronic device infections in the United States: temporal trends and causative insights. Pacing Clin Electrophysiol 2010, 33(4):414-419.
75. Cengiz M., Okutucu S., Ascioglu S., et al. Permanent pacemaker and implantable cardioverter defibrillator infections: seven years of diagnostic and therapeutic experience of a single center. Clin Cardiol 2010, 33(7):406-411.
76. Baddour L.M., Epstein A.E., Erickson C.C., et al. Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. Circulation 2010, 121(3):458-477.
77. Sohail M.R., Uslan D.Z., Khan A.H., et al. Risk factor analysis of permanent pacemaker infection. Clin Infect Dis 2007, 45(2):166-173.
78. Bloom H., Heeke B., Leon A., et al. Renal insufficiency and the risk of infection from pacemaker or defibrillator surgery. Pacing Clin Electrophysiol 2006, 29(2):142-145.
79. Mela T., McGovern B.A., Garan H., et al. Long-term infection rates associated with the pectoral versus abdominal approach to cardioverter- defibrillator implants. Am J Cardiol 2001, 88(7):750-753.
80. Da Costa A., Kirkorian G., Cucherat M., et al. Antibiotic prophylaxis for permanent pacemaker implantation: a meta-analysis. Circulation 1998, 97(18):1796-1801.
81. Belott P.H., Reynolds D.W. Permanent pacemaker and implantable cardioverter-defibrillator implantation. Clinical cardiac pacing, defibrillation, and resynchronization therapy 2007, 561-651. Saunders Elsevier, Philadelphia. 3rd edition. K.A. Ellenbogen, G.N. Kay, C.P. Lau (Eds.).
82. Lakkireddy D., Valasareddi S., Ryschon K., et al. The impact of povidone-iodine pocket irrigation use on pacemaker and defibrillator infections. Pacing Clin Electrophysiol 2005, 28(8):789-794.
83. Viola G.M., Awan L.L., Darouiche R.O. Nonstaphylococcal infections of cardiac implantable electronic devices. Circulation 2010, 121(19):2085-2091.
84. Swindle J.P., Rich M.W., McCann P., et al. Implantable cardiac device procedures in older patients: use and in-hospital outcomes. Arch Intern Med 2010, 170(7):631-637.
85. Ferguson T.B., Ferguson C.L., Crites K., et al. The additional hospital costs generated in the management of complications of pacemaker and defibrillator implantations. J Thorac Cardiovasc Surg 1996, 111(4):742-751. [discussion 51-2].
86. Kurtz S.M., Lau E., Ochoa J.A., et al. Fifteen-year trends in the infection burden for pacemakers and ICDs in the United States. Heart Rhythm 2010, 7(5 Suppl 1):S57.